nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—SLC22A2—Vinblastine—head and neck cancer	0.321	0.409	CbGbCtD
Metoprolol—CYP2D6—Hydroxyurea—head and neck cancer	0.227	0.29	CbGbCtD
Metoprolol—ABCB1—Vinblastine—head and neck cancer	0.0855	0.109	CbGbCtD
Metoprolol—CYP2D6—Vinblastine—head and neck cancer	0.0805	0.103	CbGbCtD
Metoprolol—ABCB1—Docetaxel—head and neck cancer	0.0704	0.0897	CbGbCtD
Metoprolol—Gangrene—Hydroxyurea—head and neck cancer	0.0139	0.0651	CcSEcCtD
Metoprolol—Auditory disorder NOS—Docetaxel—head and neck cancer	0.0117	0.0545	CcSEcCtD
Metoprolol—Emotional distress—Hydroxyurea—head and neck cancer	0.00714	0.0334	CcSEcCtD
Metoprolol—Emotional distress—Fluorouracil—head and neck cancer	0.00514	0.0241	CcSEcCtD
Metoprolol—Cerebrovascular disorder—Fluorouracil—head and neck cancer	0.00489	0.0229	CcSEcCtD
Metoprolol—Heartburn—Fluorouracil—head and neck cancer	0.00318	0.0149	CcSEcCtD
Metoprolol—Deafness—Vinblastine—head and neck cancer	0.0027	0.0126	CcSEcCtD
Metoprolol—Eye irritation—Fluorouracil—head and neck cancer	0.00256	0.012	CcSEcCtD
Metoprolol—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00247	0.0115	CcSEcCtD
Metoprolol—Disorientation—Hydroxyurea—head and neck cancer	0.00246	0.0115	CcSEcCtD
Metoprolol—Heartburn—Docetaxel—head and neck cancer	0.00229	0.0107	CcSEcCtD
Metoprolol—Throat sore—Docetaxel—head and neck cancer	0.00219	0.0102	CcSEcCtD
Metoprolol—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00217	0.0102	CcSEcCtD
Metoprolol—Angina pectoris—Vinblastine—head and neck cancer	0.00203	0.00952	CcSEcCtD
Metoprolol—Coma—Fluorouracil—head and neck cancer	0.002	0.00935	CcSEcCtD
Metoprolol—Breast disorder—Hydroxyurea—head and neck cancer	0.00199	0.00932	CcSEcCtD
Metoprolol—Depression—Vinblastine—head and neck cancer	0.00186	0.00869	CcSEcCtD
Metoprolol—Eye irritation—Docetaxel—head and neck cancer	0.00185	0.00865	CcSEcCtD
Metoprolol—Photosensitivity—Fluorouracil—head and neck cancer	0.00181	0.00846	CcSEcCtD
Metoprolol—Disorientation—Fluorouracil—head and neck cancer	0.00177	0.0083	CcSEcCtD
Metoprolol—Agranulocytosis—Vinblastine—head and neck cancer	0.00174	0.00813	CcSEcCtD
Metoprolol—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00173	0.00812	CcSEcCtD
Metoprolol—Weight increased—Hydroxyurea—head and neck cancer	0.00173	0.00811	CcSEcCtD
Metoprolol—Amnesia—Fluorouracil—head and neck cancer	0.00169	0.0079	CcSEcCtD
Metoprolol—Hearing impaired—Docetaxel—head and neck cancer	0.00166	0.00776	CcSEcCtD
Metoprolol—Cardiac failure—Fluorouracil—head and neck cancer	0.00163	0.00761	CcSEcCtD
Metoprolol—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00161	0.00752	CcSEcCtD
Metoprolol—Hallucination—Hydroxyurea—head and neck cancer	0.00152	0.0071	CcSEcCtD
Metoprolol—Cardiac arrest—Fluorouracil—head and neck cancer	0.00151	0.00706	CcSEcCtD
Metoprolol—Alopecia—Vinblastine—head and neck cancer	0.00148	0.00691	CcSEcCtD
Metoprolol—Lightheadedness—Docetaxel—head and neck cancer	0.00141	0.00661	CcSEcCtD
Metoprolol—Angiopathy—Hydroxyurea—head and neck cancer	0.00138	0.00647	CcSEcCtD
Metoprolol—Alopecia—Hydroxyurea—head and neck cancer	0.00135	0.00631	CcSEcCtD
Metoprolol—Angina pectoris—Fluorouracil—head and neck cancer	0.00134	0.00625	CcSEcCtD
Metoprolol—Vertigo—Vinblastine—head and neck cancer	0.00131	0.00612	CcSEcCtD
Metoprolol—Leukopenia—Vinblastine—head and neck cancer	0.0013	0.0061	CcSEcCtD
Metoprolol—Deafness—Docetaxel—head and neck cancer	0.00128	0.00599	CcSEcCtD
Metoprolol—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00126	0.00591	CcSEcCtD
Metoprolol—Hypertension—Vinblastine—head and neck cancer	0.00126	0.00588	CcSEcCtD
Metoprolol—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00125	0.00586	CcSEcCtD
Metoprolol—Pneumonia—Fluorouracil—head and neck cancer	0.00123	0.00575	CcSEcCtD
Metoprolol—Hot flush—Docetaxel—head and neck cancer	0.00122	0.00573	CcSEcCtD
Metoprolol—Menopausal symptoms—Docetaxel—head and neck cancer	0.00121	0.00568	CcSEcCtD
Metoprolol—Visual disturbance—Docetaxel—head and neck cancer	0.00121	0.00565	CcSEcCtD
Metoprolol—Conjunctivitis—Fluorouracil—head and neck cancer	0.00119	0.00556	CcSEcCtD
Metoprolol—Leukopenia—Hydroxyurea—head and neck cancer	0.00119	0.00556	CcSEcCtD
Metoprolol—Cardiac failure—Docetaxel—head and neck cancer	0.00117	0.00549	CcSEcCtD
Metoprolol—Thrombocytopenia—Vinblastine—head and neck cancer	0.00116	0.00544	CcSEcCtD
Metoprolol—Agranulocytosis—Fluorouracil—head and neck cancer	0.00114	0.00534	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00112	0.00525	CcSEcCtD
Metoprolol—Rhinitis—Fluorouracil—head and neck cancer	0.0011	0.00515	CcSEcCtD
Metoprolol—Oedema—Hydroxyurea—head and neck cancer	0.00108	0.00507	CcSEcCtD
Metoprolol—Paraesthesia—Vinblastine—head and neck cancer	0.00107	0.00499	CcSEcCtD
Metoprolol—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00106	0.00497	CcSEcCtD
Metoprolol—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00106	0.00496	CcSEcCtD
Metoprolol—Liver function test abnormal—Docetaxel—head and neck cancer	0.00106	0.00495	CcSEcCtD
Metoprolol—Skin disorder—Hydroxyurea—head and neck cancer	0.00105	0.00492	CcSEcCtD
Metoprolol—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00105	0.00489	CcSEcCtD
Metoprolol—Abdominal pain upper—Docetaxel—head and neck cancer	0.00105	0.00489	CcSEcCtD
Metoprolol—Breast disorder—Docetaxel—head and neck cancer	0.00103	0.00484	CcSEcCtD
Metoprolol—Cramp muscle—Docetaxel—head and neck cancer	0.00103	0.00483	CcSEcCtD
Metoprolol—Pain—Vinblastine—head and neck cancer	0.00102	0.00475	CcSEcCtD
Metoprolol—Constipation—Vinblastine—head and neck cancer	0.00102	0.00475	CcSEcCtD
Metoprolol—Arrhythmia—Fluorouracil—head and neck cancer	0.00098	0.00459	CcSEcCtD
Metoprolol—Feeling abnormal—Vinblastine—head and neck cancer	0.000979	0.00458	CcSEcCtD
Metoprolol—Bronchospasm—Docetaxel—head and neck cancer	0.000973	0.00456	CcSEcCtD
Metoprolol—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000971	0.00455	CcSEcCtD
Metoprolol—Alopecia—Fluorouracil—head and neck cancer	0.00097	0.00454	CcSEcCtD
Metoprolol—Dyspnoea—Hydroxyurea—head and neck cancer	0.000966	0.00452	CcSEcCtD
Metoprolol—Angina pectoris—Docetaxel—head and neck cancer	0.000964	0.00451	CcSEcCtD
Metoprolol—Somnolence—Hydroxyurea—head and neck cancer	0.000963	0.00451	CcSEcCtD
Metoprolol—Dyspepsia—Hydroxyurea—head and neck cancer	0.000953	0.00446	CcSEcCtD
Metoprolol—Abdominal pain—Vinblastine—head and neck cancer	0.000939	0.00439	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000935	0.00438	CcSEcCtD
Metoprolol—Fatigue—Hydroxyurea—head and neck cancer	0.000934	0.00437	CcSEcCtD
Metoprolol—Constipation—Hydroxyurea—head and neck cancer	0.000926	0.00434	CcSEcCtD
Metoprolol—Pain—Hydroxyurea—head and neck cancer	0.000926	0.00434	CcSEcCtD
Metoprolol—Weight increased—Docetaxel—head and neck cancer	0.000901	0.00422	CcSEcCtD
Metoprolol—Vision blurred—Fluorouracil—head and neck cancer	0.0009	0.00421	CcSEcCtD
Metoprolol—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000893	0.00418	CcSEcCtD
Metoprolol—Pneumonia—Docetaxel—head and neck cancer	0.000887	0.00415	CcSEcCtD
Metoprolol—Hypersensitivity—Vinblastine—head and neck cancer	0.000875	0.0041	CcSEcCtD
Metoprolol—Jaundice—Docetaxel—head and neck cancer	0.00086	0.00403	CcSEcCtD
Metoprolol—Conjunctivitis—Docetaxel—head and neck cancer	0.000858	0.00401	CcSEcCtD
Metoprolol—Body temperature increased—Hydroxyurea—head and neck cancer	0.000856	0.00401	CcSEcCtD
Metoprolol—Leukopenia—Fluorouracil—head and neck cancer	0.000855	0.004	CcSEcCtD
Metoprolol—Asthenia—Vinblastine—head and neck cancer	0.000852	0.00399	CcSEcCtD
Metoprolol—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000834	0.00391	CcSEcCtD
Metoprolol—Agranulocytosis—Docetaxel—head and neck cancer	0.000823	0.00385	CcSEcCtD
Metoprolol—Chest pain—Fluorouracil—head and neck cancer	0.000813	0.00381	CcSEcCtD
Metoprolol—Diarrhoea—Vinblastine—head and neck cancer	0.000813	0.0038	CcSEcCtD
Metoprolol—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000798	0.00374	CcSEcCtD
Metoprolol—Rhinitis—Docetaxel—head and neck cancer	0.000794	0.00372	CcSEcCtD
Metoprolol—Hepatitis—Docetaxel—head and neck cancer	0.000792	0.00371	CcSEcCtD
Metoprolol—Chlorphenesin—PTGS2—head and neck cancer	0.00079	0.614	CrCbGaD
Metoprolol—Confusional state—Fluorouracil—head and neck cancer	0.000786	0.00368	CcSEcCtD
Metoprolol—Dizziness—Vinblastine—head and neck cancer	0.000785	0.00368	CcSEcCtD
Metoprolol—Oedema peripheral—Docetaxel—head and neck cancer	0.00078	0.00365	CcSEcCtD
Metoprolol—Oedema—Fluorouracil—head and neck cancer	0.00078	0.00365	CcSEcCtD
Metoprolol—Connective tissue disorder—Docetaxel—head and neck cancer	0.000778	0.00364	CcSEcCtD
Metoprolol—Asthenia—Hydroxyurea—head and neck cancer	0.000777	0.00364	CcSEcCtD
Metoprolol—Nervous system disorder—Fluorouracil—head and neck cancer	0.000765	0.00358	CcSEcCtD
Metoprolol—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000763	0.00357	CcSEcCtD
Metoprolol—Visual impairment—Docetaxel—head and neck cancer	0.000763	0.00357	CcSEcCtD
Metoprolol—Tachycardia—Fluorouracil—head and neck cancer	0.000761	0.00356	CcSEcCtD
Metoprolol—Vomiting—Vinblastine—head and neck cancer	0.000755	0.00353	CcSEcCtD
Metoprolol—Headache—Vinblastine—head and neck cancer	0.000744	0.00348	CcSEcCtD
Metoprolol—Diarrhoea—Hydroxyurea—head and neck cancer	0.000741	0.00347	CcSEcCtD
Metoprolol—Eye disorder—Docetaxel—head and neck cancer	0.00074	0.00346	CcSEcCtD
Metoprolol—Cardiac disorder—Docetaxel—head and neck cancer	0.000735	0.00344	CcSEcCtD
Metoprolol—Hypotension—Fluorouracil—head and neck cancer	0.000729	0.00341	CcSEcCtD
Metoprolol—Angiopathy—Docetaxel—head and neck cancer	0.000719	0.00336	CcSEcCtD
Metoprolol—Dizziness—Hydroxyurea—head and neck cancer	0.000716	0.00335	CcSEcCtD
Metoprolol—Immune system disorder—Docetaxel—head and neck cancer	0.000715	0.00335	CcSEcCtD
Metoprolol—Mediastinal disorder—Docetaxel—head and neck cancer	0.000714	0.00334	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00071	0.00332	CcSEcCtD
Metoprolol—Arrhythmia—Docetaxel—head and neck cancer	0.000708	0.00331	CcSEcCtD
Metoprolol—Nausea—Vinblastine—head and neck cancer	0.000705	0.0033	CcSEcCtD
Metoprolol—Insomnia—Fluorouracil—head and neck cancer	0.000705	0.0033	CcSEcCtD
Metoprolol—Paraesthesia—Fluorouracil—head and neck cancer	0.0007	0.00328	CcSEcCtD
Metoprolol—Alopecia—Docetaxel—head and neck cancer	0.0007	0.00328	CcSEcCtD
Metoprolol—Dyspnoea—Fluorouracil—head and neck cancer	0.000695	0.00325	CcSEcCtD
Metoprolol—Mental disorder—Docetaxel—head and neck cancer	0.000694	0.00325	CcSEcCtD
Metoprolol—Somnolence—Fluorouracil—head and neck cancer	0.000693	0.00324	CcSEcCtD
Metoprolol—Vomiting—Hydroxyurea—head and neck cancer	0.000689	0.00322	CcSEcCtD
Metoprolol—Dyspepsia—Fluorouracil—head and neck cancer	0.000686	0.00321	CcSEcCtD
Metoprolol—Rash—Hydroxyurea—head and neck cancer	0.000683	0.0032	CcSEcCtD
Metoprolol—Dermatitis—Hydroxyurea—head and neck cancer	0.000682	0.00319	CcSEcCtD
Metoprolol—Headache—Hydroxyurea—head and neck cancer	0.000679	0.00318	CcSEcCtD
Metoprolol—Dysgeusia—Docetaxel—head and neck cancer	0.000675	0.00316	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000673	0.00315	CcSEcCtD
Metoprolol—Pain—Fluorouracil—head and neck cancer	0.000667	0.00312	CcSEcCtD
Metoprolol—Muscle spasms—Docetaxel—head and neck cancer	0.000663	0.0031	CcSEcCtD
Metoprolol—Nausea—Hydroxyurea—head and neck cancer	0.000643	0.00301	CcSEcCtD
Metoprolol—Feeling abnormal—Fluorouracil—head and neck cancer	0.000642	0.00301	CcSEcCtD
Metoprolol—Urticaria—Fluorouracil—head and neck cancer	0.000619	0.0029	CcSEcCtD
Metoprolol—Syncope—Docetaxel—head and neck cancer	0.000618	0.00289	CcSEcCtD
Metoprolol—Leukopenia—Docetaxel—head and neck cancer	0.000617	0.00289	CcSEcCtD
Metoprolol—Body temperature increased—Fluorouracil—head and neck cancer	0.000616	0.00288	CcSEcCtD
Metoprolol—Palpitations—Docetaxel—head and neck cancer	0.000609	0.00285	CcSEcCtD
Metoprolol—Loss of consciousness—Docetaxel—head and neck cancer	0.000606	0.00284	CcSEcCtD
Metoprolol—Hypertension—Docetaxel—head and neck cancer	0.000595	0.00279	CcSEcCtD
Metoprolol—Chest pain—Docetaxel—head and neck cancer	0.000587	0.00275	CcSEcCtD
Metoprolol—Arthralgia—Docetaxel—head and neck cancer	0.000587	0.00275	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000583	0.00273	CcSEcCtD
Metoprolol—Hypersensitivity—Fluorouracil—head and neck cancer	0.000574	0.00269	CcSEcCtD
Metoprolol—Dry mouth—Docetaxel—head and neck cancer	0.000574	0.00269	CcSEcCtD
Metoprolol—Confusional state—Docetaxel—head and neck cancer	0.000567	0.00266	CcSEcCtD
Metoprolol—Oedema—Docetaxel—head and neck cancer	0.000563	0.00263	CcSEcCtD
Metoprolol—Shock—Docetaxel—head and neck cancer	0.000554	0.00259	CcSEcCtD
Metoprolol—Nervous system disorder—Docetaxel—head and neck cancer	0.000552	0.00258	CcSEcCtD
Metoprolol—Pruritus—Fluorouracil—head and neck cancer	0.000552	0.00258	CcSEcCtD
Metoprolol—Thrombocytopenia—Docetaxel—head and neck cancer	0.000551	0.00258	CcSEcCtD
Metoprolol—Tachycardia—Docetaxel—head and neck cancer	0.000549	0.00257	CcSEcCtD
Metoprolol—Skin disorder—Docetaxel—head and neck cancer	0.000547	0.00256	CcSEcCtD
Metoprolol—Diarrhoea—Fluorouracil—head and neck cancer	0.000533	0.0025	CcSEcCtD
Metoprolol—Hypotension—Docetaxel—head and neck cancer	0.000526	0.00246	CcSEcCtD
Metoprolol—Dizziness—Fluorouracil—head and neck cancer	0.000516	0.00241	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000513	0.0024	CcSEcCtD
Metoprolol—Insomnia—Docetaxel—head and neck cancer	0.000509	0.00238	CcSEcCtD
Metoprolol—Paraesthesia—Docetaxel—head and neck cancer	0.000505	0.00237	CcSEcCtD
Metoprolol—Dyspnoea—Docetaxel—head and neck cancer	0.000502	0.00235	CcSEcCtD
Metoprolol—Somnolence—Docetaxel—head and neck cancer	0.0005	0.00234	CcSEcCtD
Metoprolol—Propranolol—CYP1A1—head and neck cancer	0.000497	0.386	CrCbGaD
Metoprolol—Vomiting—Fluorouracil—head and neck cancer	0.000496	0.00232	CcSEcCtD
Metoprolol—Dyspepsia—Docetaxel—head and neck cancer	0.000495	0.00232	CcSEcCtD
Metoprolol—Rash—Fluorouracil—head and neck cancer	0.000492	0.0023	CcSEcCtD
Metoprolol—Dermatitis—Fluorouracil—head and neck cancer	0.000491	0.0023	CcSEcCtD
Metoprolol—Headache—Fluorouracil—head and neck cancer	0.000488	0.00229	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000486	0.00227	CcSEcCtD
Metoprolol—Fatigue—Docetaxel—head and neck cancer	0.000485	0.00227	CcSEcCtD
Metoprolol—Pain—Docetaxel—head and neck cancer	0.000481	0.00225	CcSEcCtD
Metoprolol—Constipation—Docetaxel—head and neck cancer	0.000481	0.00225	CcSEcCtD
Metoprolol—Feeling abnormal—Docetaxel—head and neck cancer	0.000464	0.00217	CcSEcCtD
Metoprolol—Nausea—Fluorouracil—head and neck cancer	0.000463	0.00217	CcSEcCtD
Metoprolol—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00046	0.00215	CcSEcCtD
Metoprolol—Body temperature increased—Docetaxel—head and neck cancer	0.000445	0.00208	CcSEcCtD
Metoprolol—Abdominal pain—Docetaxel—head and neck cancer	0.000445	0.00208	CcSEcCtD
Metoprolol—Hypersensitivity—Docetaxel—head and neck cancer	0.000415	0.00194	CcSEcCtD
Metoprolol—Asthenia—Docetaxel—head and neck cancer	0.000404	0.00189	CcSEcCtD
Metoprolol—Pruritus—Docetaxel—head and neck cancer	0.000398	0.00186	CcSEcCtD
Metoprolol—Diarrhoea—Docetaxel—head and neck cancer	0.000385	0.0018	CcSEcCtD
Metoprolol—Dizziness—Docetaxel—head and neck cancer	0.000372	0.00174	CcSEcCtD
Metoprolol—Vomiting—Docetaxel—head and neck cancer	0.000358	0.00167	CcSEcCtD
Metoprolol—Rash—Docetaxel—head and neck cancer	0.000355	0.00166	CcSEcCtD
Metoprolol—Dermatitis—Docetaxel—head and neck cancer	0.000354	0.00166	CcSEcCtD
Metoprolol—Headache—Docetaxel—head and neck cancer	0.000353	0.00165	CcSEcCtD
Metoprolol—Nausea—Docetaxel—head and neck cancer	0.000334	0.00156	CcSEcCtD
